Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
With
National Institute of Mental Health (NIMH)
University of South Florida
Age
7–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of Obsessive-Compulsive Disorder as primary or co-primary diagnosis
Score on CY-BOCS of 16 or greater
Full Scale IQ greater than or equal to 85
English speaking
You may not be if
Receiving concurrent psychotherapy or a past adequate trial of CBT for OCD
Initiation of an antidepressant within 12 weeks before study enrollment
Initiation of an antipsychotic within 6 weeks before study enrollment
No new alternative medications, nutritionals, or therapeutic diets within 6 weeks of study enrollment
Any change in established psychotropic medication within 8 weeks before study enrollment (6 weeks for antipsychotic). Alternative medications must be stable for 6 weeks prior to baseline. Any medications must remain stable during treatment.
Current clinically significant suicidality
Suicidal behaviors within six months
DSM-IV conduct disorder
DSM-IV autism
DSM-IV bipolar
DSM-IV schizophrenia or schizo-affective disorders
Substance abuse within the past six months
Hoarding symptoms (due to difficulty implementing E/RP tasks)
Weight less than 22.5k
Epilepsy or renal insufficiency
Current and/or past history of alcohol abuse (DCS is contraindicated)
Pregnant or having unprotected sex (in females)
Presence of a significant and/or unstable medical illness that might lead to hospitalization during the study
